Thursday, November 12, 2026

AI Is Setting the Pace for Chip-Equipment Makers, While Dow and Union Pacific Cut Costs to Survive Energy Shocks

In Q3 2026 earnings calls, Lam Research's CFO guided to $8.6B of December-quarter revenue and said supply chains were the limit on AI-driven chip demand. Dow and Union Pacific talked cost cuts and fuel. We checked Dow's SEC-filed numbers against what its CFO said.

LM Salvado

November 1, 2026

AI Is Setting the Pace for Chip-Equipment Makers, While Dow and Union Pacific Cut Costs to Survive Energy Shocks
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The AI build-out is now limited by supply, not by orders

The clearest AI signal in this earnings season came from the company that makes the machines that make the chips. Lam Research's CFO, Douglas Bettinger, guided to December-quarter revenue of "$8.6 billion, plus or minus $400 million", with earnings per share of $2.33, give or take $0.15.1 That is about $8.6 billion of equipment sales in three months. Lam is a member of the S&P 500, so many readers with an index fund already own a slice of it.7

The more telling remark concerned what held the number back. Bettinger said: "This revenue guide would have been a bit higher, if not for some near-term supply chain constraints that we are actively managing."1 Asked how large unconstrained 2027 demand for wafer fab equipment (WFE, the spending on chip-factory tools) might be, he declined to give a figure: "I'm not going to put a number on what the unconstrained demand would be." The reporting summary says only that he expects it to be higher.1 The call's headline puts Lam's own preliminary 2027 WFE outlook at more than $200 billion.1 The company will not say how far above that unconstrained demand sits.

For people following AI, that is a useful correction to the usual story. The bottleneck in this account is not a shortage of customers. It is the physical supply chain. The same coverage notes a falling China share of Lam's business, which is a second drag on the guide.1 The call also reports record revenue and operating margin above 40% for the first time, according to CEO Timothy Archer.1

Our knowledge graph links Lam to the places AI spending lands. It records Lam as a supplier to high-bandwidth memory and as the developer of advanced packaging technologies. It also lists ASML Holding and FormFactor among its competitors.7 This is a relationship map, not a market-share claim, and we draw no revenue conclusions from it.

Where AI actually shows up elsewhere: efficiency and early planning

Outside semiconductors, AI appears in this season mostly as a cost-and-productivity story. AudioEye's CEO, Kelly Georgevich, said the quarter was driven by "efficiencies and increased AI use across the company". She raised the Q4 adjusted EBITDA annualized run rate to over $17 million, up from a prior $15 million, and guided to roughly 50% adjusted EBITDA growth in 2026.5 These are management's own statements, not audited results.

On the enterprise side, SAP's launch announcement named Morgan Foods among customers for its Joule Work and Joule Assistants agents. CEO Christian Klein said "The Autonomous Enterprise has arrived."6 We should be careful here. The excerpt we hold shows a vendor's marketing claim and a customer list. It does not show what Morgan Foods deploys, or any results. Treat it as early adoption planning, not proof of returns.

The other camp: self-help, fuel and liquidity

Cyclical CFOs spent their calls on what they control. Dow's Jeffrey Tate said the company remains committed to "approximately $1.3 billion in net benefits this year as well as $1.3 billion in 2027".3 He also said "our SARD was actually down $130 million", meaning selling and administrative costs fell from the prior quarter.3 CEO Karen Carter put the headcount side plainly: the plan includes cutting about 4,500 Dow roles, with roughly 70% already implemented.3

Why is the cost-cutting urgent? Dow's filed numbers show the squeeze. Revenue fell from $44.6 billion in FY2023 to $43.0 billion in FY2024 and $40.0 billion in FY2025.2 Earnings per share went from $0.82 to $1.57 and then to a loss of $3.70 per share in FY2025.2 Operating cash flow shrank from $5.2 billion in FY2023 to $2.9 billion in FY2024 and just $1.0 billion in FY2025.2 Those figures come from SEC filings and are fidelity-checked.

The cushion is cash and time. Dow reported $4.11 billion of cash at Q1 2026, compared with $1.47 billion a year earlier at Q1 2025.2 Tate said: "We have approximately $14 billion of liquidity and no substantive debt maturities until 2029."3 Set against FY2025 revenue of about $40 billion, that liquidity is roughly a third of a year of sales.2 Tate also cited Q3 free cash flow of "$1.1 billion".3 Another point from the verified data is that the share count rose from 702.3 million in FY2023 to 717.5 million in FY2025, so each dollar of profit is split across more shares.2

Tate also said "Persistently high energy costs continue to challenge industry economics", with European operations hit hardest.3 For the fourth quarter, he said seasonality will be "largely offset by more than $100 million of lower sequential turnaround spending", and that polyethylene integrated margins should improve by about $0.02 per pound.3 The headline of the Dow coverage puts Q4 EBITDA at about $1.5 billion.3

Union Pacific: fuel up, merger cash building

At Union Pacific, CFO Jennifer Hamann said: "Fuel expense grew 69% on a 64% increase in average fuel price", with the average price per gallon rising from $2.56 to $4.21.4 The company still reported record results: net income of $2.1 billion and adjusted EPS up 15% to $3.53, on 6% volume growth, according to CEO Vincenzo Vena.4 It affirmed high single-digit 2026 reported EPS growth while lifting 2026 capital spending to $3.5 billion.4 Hamann added: "We will continue growing our cash reserves in anticipation of closing the Norfolk Southern merger in the second half of 2027."4

How much to trust the source

All the call summaries above come from NewsEOD. By our measurement, 61% of 1,119 claims checked against that feed's earnings-call coverage held up.1,3,4,5 The SAP piece comes from a feed where 52% of 6,220 checked claims held up.6 That is a modest hit rate. It is why we lean on SEC-filed figures for Dow and quote executives verbatim rather than paraphrasing the summaries. Executive quotes are what the company said, not independent confirmation of it.

What to watch

  • Whether Lam's supply constraints ease, and whether it will ever put a number on unconstrained 2027 demand.1
  • Dow's delivery against its $1.3 billion 2027 self-help target, and its stated 2027 cash conversion of 70% to 80%.3
  • How AI efficiency claims, like AudioEye's raised run rate, show up in reported results rather than guidance.5
  • Union Pacific's fuel costs and cash build ahead of the Norfolk Southern close in the second half of 2027.4

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleSeeking Alpha· October 26, 2026
    AudioEye expects Q4 adjusted EBITDA run rate over $17M, supported by AI efficiencies and new products
  2. [2]News articleSeeking Alpha· October 22, 2026
    Dow expects about $1.5B Q4 EBITDA while targeting $1.3B of self-help benefits in 2027
  3. [3]News articleSeeking Alpha· October 22, 2026
    Lam projects more than $200B 2027 WFE as Aether revenue target rises to $2.5B by decade end
  4. [4]News articleYahoo Finance· October 6, 2026
    SAP Puts the Autonomous Enterprise to Work
  5. [5]News articleSeeking Alpha· October 22, 2026
    Union Pacific affirms 2026 reported EPS growth in the high single-digit range while lifting 2026 capex to $3.5B
  6. [6]News articleSeeking Alpha· July 21, 2026
    Genuine Parts outlines 2026 adjusted EPS of $7.50-$8.00 while targeting separation in Q1 2027
  7. [7]News articleSeeking Alpha· October 22, 2026
    JAKKS outlines 2027 slate with Sonic the Hedgehog 4 in March as Toys 'R' Us opens 120 stores
  8. [8]News articleSeeking Alpha· October 20, 2026
    Mercantile Bank forecasts 5%-7% annualized 4Q loan growth as it projects $0.6M quarterly cost reduction starting April 1, 2027
  9. [9]Press releaseGlobeNewswire· July 14, 2026
    NFI Announces Pricing of C$350 million Senior Unsecured Notes Offering and Amendment and Extension of Existing Senior Credit Facilities
  10. [10]News articleSeeking Alpha· July 23, 2026
    Origin Bancorp anticipates high single-digit net interest income growth as it targets at least 1.15% ROA in Q4
  11. [11]News articleSeeking Alpha· October 22, 2026
    Pinnacle outlines $150M-$160M 2026 BHG income while targeting 10.25% CET1 and March 2027 conversion
  12. [12]Press releaseGlobeNewswire· July 28, 2026
    SMCP - Résultat S1 2026

In this story

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com